<h3>Gainers</h3>
<ul>
<li>Cellectar Biosciences (NASDAQ:CLRB) stock moved upwards by 45.0% to $4.1 during Tuesday's pre-market session. The market value of their outstanding shares is at $11.9 million. </li>
<li>Viridian Therapeutics (NASDAQ:VRDN) shares increased by 27.38% to $17.91. The market value of their outstanding shares is at $1.4 billion. As per the press release, Q1 earnings came out today. </li>
<li>Cytokinetics (NASDAQ:CYTK) shares increased by 26.95% to $83.86. The market value of their outstanding shares is at $8.2 billion. The company's, Q1 earnings came out today. </li>
<li>Biodexa Pharmaceuticals (NASDAQ:BDRX) shares moved upwards by 24.99% to $3.9. The market value of their outstanding shares is at $10.1 million. </li>
<li>Edgewise Therapeutics (NASDAQ:EWTX) stock rose 20.82% to $38.0. The market value of their outstanding shares is at $3.3 billion. </li>
<li>Regentis Biomaterials (AMEX:RGNT) shares increased by 17.64% to $3.0. The company's market cap stands at $13.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>GeneDx Holdings (NASDAQ:WGS) stock fell 41.9% to $39.48 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.9 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Embecta (NASDAQ:EMBC) stock decreased by 31.9% to $6.3. The company's market cap stands at $547.7 million. As per the news, the Q2 earnings report came out today. </li>
<li>Picard Medical (AMEX:PMI) stock decreased by 29.6% to $0.25. The company's market cap stands at $26.5 million. </li>
<li>CNS Pharmaceuticals (NASDAQ:CNSP) shares decreased by 23.35% to $6.01. The market value of their outstanding shares is at $6.3 million. </li>
<li>Akanda (NASDAQ:AKAN) stock declined by 22.41% to $31.88. The company's market cap stands at $21.9 million. </li>
<li>Lunai Bioworks (NASDAQ:LNAI) shares declined by 18.98% to $0.26. The company's market cap stands at $11.7 million. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EMBC

BDRX

CLRB

In Tuesday's pre-market session, Cellectar Biosciences (CLRB) saw a significant gain of 45.0%, reaching $4.1, while Viridian Therapeutics (VRDN) rose by 27.38% to $17.91. Cytokinetics (CYTK) increased by 26.95% to $83.86. Other gainers included Biodexa Pharmaceuticals (BDRX) and Edgewise Therapeutics (EWTX). Conversely, GeneDx Holdings (WGS) experienced a sharp decline of 41.9% to $39.48, followed by Embecta (EMBC) down 31.9% to $6.3. Other losers included Picard Medical (PMI) and CNS Pharmaceuticals (CNSP).

benzinga_article

Embecta

Biodexa Pharmaceuticals

Cellectar Bioscience

Cytokinetics

Edgewise Therapeutics

Viridian Therapeutics

GeneDx

CNS Pharma

Picard Medical

Health Care Select Sector SPDR

iShares Biotechnology ETF

iShares US Medical Devices

ALPS Medical Breakthrough

Invesco Nasdaq Biotechnology ETF

iShares US Pharma

Proshares Ultra Nasdaq Biotech

Invesco Biotechnology & Genome ETF

VG Health

iShares Global Healthcare

First Trust NYSE Arca Biotech Index Fd

Direxion Pharma & Medical Bull 3X

Direxion S&P Biotech Bull 3X

Ark Genomic Revolution ETF

SPDR S&P Biotech

iShares US Healthcare Providers

iShares Genomics Immunology and Healthcare ETF

VanEck Biotech ETF

SPDR S&P Health Equip

Regentis Biomaterials

Akanda

Lunai Bioworks

GeneDx - CW27

12 Health Care Stocks Moving In Tuesday's Pre-Market Session